中國醫藥大學機構典藏 China Medical University Repository, Taiwan:Item 310903500/50290
English  |  正體中文  |  简体中文  |  全文笔数/总笔数 : 29490/55136 (53%)
造访人次 : 1577926      在线人数 : 261
RC Version 7.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜寻范围 查询小技巧:
  • 您可在西文检索词汇前后加上"双引号",以获取较精准的检索结果
  • 若欲以作者姓名搜寻,建议至进阶搜寻限定作者字段,可获得较完整数据
  • 进阶搜寻
    主页登入上传说明关于CMUR管理 到手机版


    jsp.display-item.identifier=請使用永久網址來引用或連結此文件: http://ir.cmu.edu.tw/ir/handle/310903500/50290


    题名: 研究CCL3在人類軟骨肉瘤移行所扮演的角色
    Study the role of CCL3 in migration in human chondrosarcoma cells
    作者: 陳清元;Chin-Yuan Chen
    贡献者: 基礎醫學研究所碩士班
    关键词: CCL3;人類軟骨肉瘤;移行;CCL3;human chondrosarcoma;migration
    日期: 2013-02-05
    上传时间: 2013-10-02 11:16:43 (UTC+8)
    出版者: 中國醫藥大學
    摘要: CCL3是CCL family (chemokine (C-C motif) ligand family) 中的一員,又稱為MIP-1α (macrophage inflammatory protein-1α)。是一種細胞因子,在細胞中參與發炎反應、多形核白血球的活化,也活躍於腫瘤細胞。軟骨肉瘤是一種高度惡性的腫瘤,且具有轉移性。基質金屬蛋白酶(matrix metalloproteinase)對細胞的行為,如細胞增殖,遷移,分化和血管生成中都發揮了重要作用。然而CCL3與軟骨肉瘤的移行關係並不明朗。本實驗中我們發現CCL3可以透過CCR5 receptor增加人類軟骨肉瘤細胞(JJ012&SW1353)的移行和MMP-2的表現。本實驗使用CCR5單株抗體可以有效地抑制CCL3誘導細胞移行能力和MMP-2的產生。給予CCL3後也會促進AMPK (AMP-activated protein kinase)、p38、IKKα/β及p65的活化;使用AMPK、 p38、IKKα/β和NF-κB (nuclear factor kappaB)專一性訊息傳遞抑制劑,都會抑制CCL3增加人類軟骨肉瘤細胞的移行能力與MMP-2的產生。細胞轉染AMPK siRNA、DN-p38、DN-IKKα/β、MMP-2 siRNA及CCL3 shRNA也可以有效降低CCL3促使癌症細胞的轉移。由我們的實驗結果指出CCL3會經過CCR5 receptor調控人類軟骨肉瘤細胞的移行能力與MMP-2的表現,而 AMPK / p38 / NF-κB 路徑參與其中。
    Chemokine (C-C motif) ligand 3 (CCL3) is a protein that in humans is encoded by the CCL3 gene. CCL3, also known as Macrophage inflammatory protein-1α, is a cytokine involved in inflammation, activation of polymorphonuclear leukocytes and was detected in infiltrating cells and tumor cells. Chondrosarcoma is a type of highly malignant tumor and cause distant metastasis. Matrix metalloproteinases (MMPs) play a major role on cell behaviors such as cell proliferation, migration, differentiation and angiogenesis. However, the effects of CCL3 in migration and MMP-2 expression in chondrosarcoma cells are largely unknown. Here we found that CCL3 increased the migration and expression of MMP-2 in human chondrosarcoma cells (JJ012&SW1353 cells). Activations of CCR5, AMPK, p38, and nuclear factor-κB (NF-κB) pathways after CCL3 treatment were demonstrated, and CCL3-induced the expression of MMP-2 and migration activity was also inhibited by the specific inhibitor and dominant mutant of CCR5, AMPK, p38, and NF-κB cascades. Taken together, our result indicated that CCL3 enhances the cell migration ability of human chondrosarcoma cells by increasing MMP-2 expression via CCR5 receptor, AMPK, p38, and NF-κB pathway.
    显示于类别:[基礎醫學研究所] 博碩士論文

    文件中的档案:

    档案 描述 大小格式浏览次数
    index.html0KbHTML130检视/开启
    index.html0KbHTML8检视/开启


    在CMUR中所有的数据项都受到原著作权保护.

    TAIR相关文章

     


    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回馈